XPH
State Street SPDR S&P Pharmaceuticals ETF
Price Chart
Latest Quote
$57.89
+1.58 (+2.80%)
Current Price
| Previous Close | $56.31 |
| Open | $56.70 |
| Day High | $58.30 |
| Day Low | $56.85 |
| Volume | 54,025 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.64% |
| Shares Outstanding | 5.50M |
| Net Assets | $352.88M |
| Expense Ratio | 0.35% |
| Category | Health |
| Fund Family | State Street Investment Management |
| Net Asset Value | $57.95 |
| Premium/Discount | -0.11% |
| Quarterly Dividend Yield | 0.64% |
| P/E Ratio | 18.90 |
| Exchange | PCX |
📊 ETF Analysis
Company Data
| Book/sh | $52.02 |
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 1.10 |
Analyst Data
Technical Indicators
| SMA20 | $57.62 |
| SMA50 | $57.08 |
| SMA200 | $53.52 |
| RSI | 51.06 |
| ATR | 1.1229 |
| Rel Volume | 0.39 |
Performance History
| Week | -2.08% |
| Month | -6.03% |
| Quarter | +4.04% |
| 6 Months | +5.79% |
| YTD | +3.43% |
| Year | +39.73% |
| 3 Years | +50.08% |
| 5 Years | +20.41% |
| 10 Years | +39.91% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $57.04 | 21,400 |
| 2026-06-04 | $57.89 | 61,900 |
| 2026-06-03 | $56.32 | 116,700 |
| 2026-06-02 | $55.70 | 211,000 |
| 2026-06-01 | $57.39 | 48,700 |
| 2026-05-29 | $58.25 | 30,500 |
| 2026-05-28 | $58.58 | 16,700 |
| 2026-05-27 | $58.30 | 18,000 |
| 2026-05-26 | $58.08 | 40,000 |
| 2026-05-22 | $57.79 | 21,400 |
| 2026-05-21 | $57.87 | 16,600 |
| 2026-05-20 | $57.25 | 17,300 |
| 2026-05-19 | $55.81 | 241,400 |
| 2026-05-18 | $55.77 | 94,700 |
| 2026-05-15 | $56.83 | 41,500 |
| 2026-05-14 | $58.86 | 19,200 |
| 2026-05-13 | $59.10 | 20,100 |
| 2026-05-12 | $58.23 | 23,300 |
| 2026-05-11 | $58.38 | 28,200 |
| 2026-05-08 | $58.88 | 14,800 |
| 2026-05-07 | $59.74 | 24,700 |
| 2026-05-06 | $60.70 | 34,800 |
About State Street SPDR S&P Pharmaceuticals ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
📰 Latest News
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Zacks • 2026-06-05T10:20:03Z
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks • 2026-06-03T10:20:02Z
These 5 Undervalued ETFs Could Be Bargains Right Now
24/7 Wall St. • 2026-02-26T12:55:24Z
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning
24/7 Wall St. • 2026-02-18T16:58:50Z
Biopharma 2026 outlook: Keep an eye out for M&A
Yahoo Finance Video • 2025-12-24T11:30:06Z3 Undervalued ETFs to Buy Before 2026
Zacks • 2025-12-10T12:00:00Z
Pharma ETF (XPH) Hits a New 52-Week High
Zacks • 2025-12-09T11:00:00Z
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
Zacks • 2025-11-14T12:59:00Z
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
Zacks • 2025-10-06T10:57:00Z
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff
Investor's Business Daily • 2025-09-26T20:22:07Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.